Adjunctive therapy in Parkinson's disease: the role of rasagiline
Kathryn D Gaines,1 Vanessa K Hinson21Department of Neurology, Aurora Advanced Healthcare, Milwaukee, WI, 2Department of Neurosciences, Movement Disorders Program, Medical University of South Carolina, Charleston, SC, USAAbstract: Parkinson's disease is the second most common neurodegener...
Saved in:
Main Authors: | Gaines KD, Hinson VK |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/aa42f0d91b954ce2a8df80a3d2961a92 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rasagiline in treatment of Parkinson’s disease
by: Lakshmi Nayak, et al.
Published: (2008) -
Review: management of Parkinson's disease
by: Pedrosa DJ, et al.
Published: (2013) -
Do neurologists in Germany adhere to the national Parkinson's disease guideline?
by: Sabrina Schröder, et al.
Published: (2011) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
by: Leahy JT, et al.
Published: (2011) -
Editor's choice
by: Pinder RM
Published: (2012)